CAD and pancreatic neoplasm: In summary, we have demonstrated that CPs can be used as adjuvants to enhance synergistically the activity of GEM in pancreatic cancer cell lines, which present intrinsic resistance to this chemotherapeutic through modulation of ROS levels.